Skip to main content
PMC home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1999 May-Jun;5(3):329–335. doi: 10.3201/eid0503.990303

Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe.

H C Wegener 1, F M Aarestrup 1, L B Jensen 1, A M Hammerum 1, F Bager 1
PMCID: PMC2640785  PMID: 10341169

Abstract

Supplementing animal feed with antimicrobial agents to enhance growth has been common practice for more than 30 years and is estimated to constitute more than half the total antimicrobial use worldwide. The potential public health consequences of this use have been debated; however, until recently, clear evidence of a health risk was not available. Accumulating evidence now indicates that the use of the glycopeptide avoparcin as a growth promoter has created in food animals a major reservoir of Enterococcus faecium, which contains the high level glycopeptide resistance determinant vanA, located on the Tn1546 transposon. Furthermore, glycopeptide-resistant strains, as well as resistance determinants, can be transmitted from animals to humans. Two antimicrobial classes expected to provide the future therapeutic options for treatment of infections with vancomycin-resistant enterococci have analogues among the growth promoters, and a huge animal reservoir of resistant E. faecium has already been created, posing a new public health problem.

Full Text

The Full Text of this article is available as a PDF (85.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarestrup F. M., Ahrens P., Madsen M., Pallesen L. V., Poulsen R. L., Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996 Aug;40(8):1938–1940. doi: 10.1128/aac.40.8.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bager F., Madsen M., Christensen J., Aarestrup F. M. Avoparcin used as a growth promoter is associated with the occurrence of vancomycin-resistant Enterococcus faecium on Danish poultry and pig farms. Prev Vet Med. 1997 Jul;31(1-2):95–112. doi: 10.1016/s0167-5877(96)01119-1. [DOI] [PubMed] [Google Scholar]
  3. Centers for Disease Control and Prevention (CDC) Nosocomial enterococci resistant to vancomycin--United States, 1989-1993. MMWR Morb Mortal Wkly Rep. 1993 Aug 6;42(30):597–599. [PubMed] [Google Scholar]
  4. Coque T. M., Tomayko J. F., Ricke S. C., Okhyusen P. C., Murray B. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996 Nov;40(11):2605–2609. doi: 10.1128/aac.40.11.2605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Edmond M. B., Ober J. F., Weinbaum D. L., Pfaller M. A., Hwang T., Sanford M. D., Wenzel R. P. Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin Infect Dis. 1995 May;20(5):1126–1133. doi: 10.1093/clinids/20.5.1126. [DOI] [PubMed] [Google Scholar]
  6. Leclercq R., Derlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med. 1988 Jul 21;319(3):157–161. doi: 10.1056/NEJM198807213190307. [DOI] [PubMed] [Google Scholar]
  7. Leclercq R., Derlot E., Weber M., Duval J., Courvalin P. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1989 Jan;33(1):10–15. doi: 10.1128/aac.33.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Noble W. C., Virani Z., Cree R. G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus. FEMS Microbiol Lett. 1992 Jun 1;72(2):195–198. doi: 10.1016/0378-1097(92)90528-v. [DOI] [PubMed] [Google Scholar]
  9. Schouten M. A., Voss A., Hoogkamp-Korstanje J. A. VRE and meat. Lancet. 1997 Apr 26;349(9060):1258–1258. doi: 10.1016/s0140-6736(05)62461-0. [DOI] [PubMed] [Google Scholar]
  10. Silverman J., Thal L. A., Perri M. B., Bostic G., Zervos M. J. Epidemiologic evaluation of antimicrobial resistance in community-acquired enterococci. J Clin Microbiol. 1998 Mar;36(3):830–832. doi: 10.1128/jcm.36.3.830-832.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Thal L. A., Chow J. W., Mahayni R., Bonilla H., Perri M. B., Donabedian S. A., Silverman J., Taber S., Zervos M. J. Characterization of antimicrobial resistance in enterococci of animal origin. Antimicrob Agents Chemother. 1995 Sep;39(9):2112–2115. doi: 10.1128/aac.39.9.2112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Thal L., Donabedian S., Robinson-Dunn B., Chow J. W., Dembry L., Clewell D. B., Alshab D., Zervos M. J. Molecular analysis of glycopeptide-resistant Enterococcus faecium isolates collected from Michigan hospitals over a 6-year period. J Clin Microbiol. 1998 Nov;36(11):3303–3308. doi: 10.1128/jcm.36.11.3303-3308.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Van der Auwera P., Pensart N., Korten V., Murray B. E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996 May;173(5):1129–1136. doi: 10.1093/infdis/173.5.1129. [DOI] [PubMed] [Google Scholar]
  14. Wegener H. C., Madsen M., Nielsen N., Aarestrup F. M. Isolation of vancomycin resistant Enterococcus faecium from food. Int J Food Microbiol. 1997 Mar 18;35(1):57–66. doi: 10.1016/s0168-1605(96)01221-4. [DOI] [PubMed] [Google Scholar]
  15. van den Bogaard A. E., Jensen L. B., Stobberingh E. E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997 Nov 20;337(21):1558–1559. doi: 10.1056/NEJM199711203372117. [DOI] [PubMed] [Google Scholar]
  16. van den Braak N., van Belkum A., van Keulen M., Vliegenthart J., Verbrugh H. A., Endtz H. P. Molecular characterization of vancomycin-resistant enterococci from hospitalized patients and poultry products in The Netherlands. J Clin Microbiol. 1998 Jul;36(7):1927–1932. doi: 10.1128/jcm.36.7.1927-1932.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES